Abstract

To examine possible association of plasma levels of biomarkers of inflammation and hemostatic activation with the incidence of thrombotic complications after thermal ablation of the great saphenous vein (GSV). This was a prospective cohort study of 120 patients with primary chronic venous disease and reflux limited to the GSV and its tributaries, who were to undergo treatment with radiofrequency ablation of the GSV. Plasma concentration of C-reactive protein (high-sensitivity CRP) and D-dimer were measured immediately prior to the ablation procedure, and in 64 patients, at 20 to 36 hours, 1 week, and 1 month after the treatment. A complete bilateral duplex ultrasound scan was performed prior to treatment, within the first 36 hours and at 1 month after treatment. Incidence of thrombotic complications was based on findings of duplex ultrasound scans. Sixteen patients developed thrombotic complications. These included seven endovenous heat-induced thromboses, seven thromboses of untreated superficial veins, one thrombosis of the posterior tibial vein, and one gastrocnemius vein thrombosis. In two patients, endovenous heat-induced thromboses coincided with superficial phlebitis. Multivariate analysis showed that patients who had a combination of normal baseline levels of CRP and elevated levels of D-dimer were more than seven times more likely to develop thrombotic complications compared with all other patients (odds ratio, 7.3; 95% confidence interval, 2.2-23.9; P= .002). Both CRP and D-dimer levels significantly increased at 24 to 36 hours and returned to the baseline values at 1 month after the treatment. The D-dimer levels were significantly higher in patients with thrombotic complications at the baseline, 24 to 36 hours and 1 week after the treatment but became not statistically significant a month after the treatment. These findings suggest that preoperative activation of the hemostatic system plays an important role in the development of thrombotic complications after thermal ablation of the GSV and that such activation can be detected by commonly used clinical practice laboratory tests.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.